v1
Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group.
Identifier:nobleid.org/w1/20260515/AF9CDC97
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/AF9CDC97)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims